RUNX1 Is a Key Target in t(4;11) Leukemias that Contributes to Gene Activation through an AF4-MLL Complex Interaction by Wilkinson, A, Ballabio, E, Geng, H, Geng, H, Geng, H, North, P, Tapia, M, Kerry, J, Biswas, D, Roeder, R, Allis, C, Melnick, A, Melnick, A, de Bruijn, M, Milne, T

Optimisation of an HHG-seeded harmonic cascade FEL design for the NLS project by Dunning, D, Thompson, N, McNeil, B, Bartolini, R, Huang, Z, Geng, H

Identification of cyclin-dependent kinase (CDK) 6 as a novel p65 NK-kappaB Ser536 kinase by Buss, H, Doerrie, A, Geng, H, Kaldis, P, Wait, R, Saklatvala, J, Schmitz, L, Kracht, M

MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation. by Godfrey, L, Kerry, J, Thorne, R, Repapi, E, Davies, J, Tapia, M, Ballabio, E, Hughes, J, Geng, H, Konopleva, M, Milne, T

RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction. by Wilkinson, A, Ballabio, E, Geng, H, North, P, Tapia, M, Kerry, J, Biswas, D, Roeder, R, Allis, C, Melnick, A, de Bruijn, M, Milne, T

Integrative Genome Wide DNA Methylation and Gene Expression Analysis Reveals Biological and Clinical Insights In Adult Acute Lymphoblastic Leukemia by Geng, H, Neuberg, D, Paietta, E, Deng, X, Li, Y, Xin, Y, Racevskis, J, Ketterling, R, Richards, S, Tallman, MS, Rowe, J, Litzow, MR, Elemento, O, Melnick, A

Integrative Genome-Wide DNA Methylation and Gene Expression Analysis Reveals Biological and Clinical Insights In Adult Acute Lymphoblastic Leukemia by Geng, H, Neuberg, D, Paietta, E, Deng, X, Li, Y, Xin, Y, Racevskis, J, Ketterling, R, Richards, S, Tallman, MS, Rowe, J, Litzow, MR, Elemento, O, Melnick, A

Integrative Genome Wide DNA Methylation and Gene Expression Analysis Reveals Biological and Clinical Insights In Adult Acute Lymphoblastic Leukemia by Geng, H, Neuberg, D, Paietta, E, Deng, X, Li, Y, Xin, Y, Racevskis, J, Ketterling, R, Richards, S, Tallman, MS, Rowe, J, Litzow, MR, Elemento, O, Melnick, A

Association of healthy lifestyle with incident cardiovascular diseases among hypertensive and normotensive Chinese adults by Su, J, Geng, H, Chen, L, Fan, X, Zhou, J, Wu, M, Lu, Y, Hua, Y, Jin, J, Guo, Y, Lv, J, Pei, P, Chen, Z, Tao, R

MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. by Kerry, J, Godfrey, L, Repapi, E, Tapia, M, Blackledge, N, Ma, H, Ballabio, E, O'Byrne, S, Ponthan, F, Heidenreich, O, Roy, A, Roberts, I, Konopleva, M, Klose, R, Geng, H, Milne, T

Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia. by Geng, H, Brennan, S, Milne, T, Chen, W, Li, Y, Hurtz, C, Kweon, S, Zickl, L, Shojaee, S, Neuberg, D, Huang, C, Biswas, D, Xin, Y, Racevskis, J, Ketterling, R, Luger, S, Lazarus, H, Tallman, MS, Rowe, J, Litzow, MR, Guzman, M, Allis, C, Roeder, R, Müschen, M, Paietta, E

MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia by Crump, NT, Smith, AL, Godfrey, L, Dopico-Fernandez, AM, Denny, N, Harman, JR, Hamley, JC, Jackson, NE, Chahrour, C, Riva, S, Rice, S, Kim, J, Basrur, V, Fermin, D, Elenitoba-Johnson, K, Roeder, RG, Allis, CD, Roberts, I, Roy, A, Geng, H, Davies, JOJ, Milne, TA

Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia by Geng, H, Brennan, S, Milne, T, Chen, W, Li, Y, Hurtz, C, Kweon, S, Zickl, L, Shojaee, S, Neuberg, D, Huang, C, Biswas, D, Xin, Y, Racevskis, J, Ketterling, R, Luger, S, Lazarus, H, Tallman, MS, Rowe, J, Litzow, MR, Guzman, M, David Allis, C, Roeder, R, Müschen, M, Paietta, E

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. by Choi, W, Weisenburger, D, Greiner, T, Piris, M, Banham, A, Delabie, J, Braziel, R, Geng, H, Iqbal, J, Lenz, G, Vose, J, Hans, C, Fu, K, Smith, L, Li, M, Liu, Z, Gascoyne, R, Rosenwald, A, Ott, G, Rimsza, L, Campo, E, Jaffe, E, Jaye, D, Staudt, L, Chan, W

Metabolic gatekeeper function of B-lymphoid transcription factors by Chan, LN, Chen, Z, Braas, D, Lee, J-W, Xiao, G, Geng, H, Cosgun, KN, Hurtz, C, Shojaee, S, Cazzaniga, V, Schjerven, H, Ernst, T, Hochhaus, A, Kornblau, SM, Konopleva, M, Pufall, MA, Cazzaniga, G, Liu, GJ, Milne, TA, Koeffler, HP, Ross, TS, Sánchez-García, I, Borkhardt, A, Yamamoto, KR, Dickins, RA, Graeber, TG, Müschen, M

MLL-rearranged acute lymphoblastic leukemias activate BCL-2 through H3K79 methylation and are sensitive to the BCL-2-specific antagonist ABT-199 by Benito, J, Godfrey, L, Kojima, K, Hogdal, L, Wunderlich, M, Geng, H, Marzo, I, Harutyunyan, K, Golfman, L, North, P, Kerry, J, Ballabio, E, Chonghaile, T, Gonzalo, O, Qiu, Y, Jeremias, I, Debose, L, O'Brien, E, Ma, H, Zhou, P, Jacamo, R, Park, E, Coombes, K, Zhang, N, Thomas, D, O'Brien, S, Kantarjian, H, Leverson, J, Kornblau, S, Andreeff, M, Müschen, M, Zweidler-McKay, P, Mulloy, J, Letai, A, Milne, T, Konopleva, M